In this episode of The Feldman Protocol, how does one family doctor's decades-long frustration with a "progressive, incurable" disease lead to a fundamentally different approach to patient care? Dave Feldman and David Unwin (MD) explore the pivotal 2012 patient encounter that reshaped Unwin's practice, the psychology of behavior change and food addiction, real-world data from a 10,000-patient NHS cohort, collaborative medicine versus authoritarian care, GLP-1 drugs as a last resort, and AI's emerging role in clinical decision-making.
🔥 This episode is sponsored by us --
Own Your Labs 👉 `https://ownyourlabs.com/sp/44`
Private blood testing services
🩸Over 300 blood tests
💰Extremely affordable
❤️ We love our customers
(Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! 🙏)
🔗 CONNECT WITH DAVE FELDMAN:
Main Channel: `https://youtube.com/@realDaveFeldman`
X/Twitter: `https://x.com/realDaveFeldman`
Instagram: `https://instagram.com/realDaveFeldman`
Website: `https://thefeldmanprotocol.com`
⏱ Chapters
0:00 – Introduction & cold open
1:24 – David Unwin's background
13:07 – Generational health trends observed
20:19 – Conventional medicine & early career
39:14 – The art vs. science of medicine
52:28 – The ACCORD study discussed
1:04:45 – The 2012 pivotal patient encounter
1:17:13 – Publishing the first 18-patient audit
1:30:06 – Unexpected behavioral changes on diet
1:45:09 – Collaborative medicine & patient partnership
2:02:32 – Evolutionary context for modern diet
2:13:06 – Food addiction & maintenance challenges
2:35:12 – GLP-1 drugs: a nuanced discussion
2:47:23 – Questions from the desk
3:09:27 – Unwin's real-world remission data
3:16:03 – AI in medicine & society
3:44:36 – Technology, freedom & human adaptability
3:59:46 – Closing & where to find David Unwin
#FeldmanProtocol #DaveFeldman #DavidUnwin #LowCarb #MetabolicHealth #Type2Diabetes #DiabetesRemission #BehaviorChange #FoodAddiction #CollaborativeMedicine #NHSData #GLP1 #NutritionalScience #InsulinResistance #RealWorldData #PublicHealthCollaboration #LowCarbGP #AIInMedicine #FamilyMedicine
